Punya Abbhi, Chief Operating Officer at Celegence, said:
“We are so glad to support Navignostics in the process of EU IVDR PMS documentation. The CAPTIS™ system will create significant time savings for Navignostics’ medical writing process by reducing manual efforts and helping writers organize and analyze data more seamlessly.
Navignostic’s mission of designing client-oriented personalized solutions resonates with our values. Celegence realizes our client’s unique demands, and we aspire to provide efficient planning and cost-effective solutions through our innovative technologies.”
Dr. Stéphane Chevrier, Co-Founder at Navignostics, said:
“We are genuinely excited to work with Celegence and use CAPTIS™ for our IVDR documentation, including literature reviews. I believe the CAPTIS™ platform can better support our compliance efforts related to launching and maintaining focused cancer treatments and medications.”